Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Toron, Inc. Provides Corporate Update On iMedScan

Posted on: 17 Dec 17

MIAMI, Dec. 14, 2017 /PRNewswire/ -- Toron, Inc.  (OTC Pink: TRON) provided its stockholders today with a corporate update.

Toron, Inc.'s President Rene Ortiz Morentin announces that iMedScan Corp is negotiating an agreement to facilitate a Blockchain Application to manage iMedScan's HealthCare Technology Applications.  Mr. Ortiz Morentin stated that iMedScan Blockchain technology will enable:


A document sharing platform that would facilitate the exchange and processing of confidential documents. The process will include an online portal/mobile application where users can login and securely upload sensitive documents to be shared with their clients. This platform will allow iMedScan to seamlessly add more clients to the network and start exchanging confidential documents with them using private and/or public keys. Specifically, the iMedScan application has two customer contract forms for recurring revenue, e.g. Acuant corporation cloud based contract and iMedScan contract for monthly recurring revenue contract which will be digitized in its blockchain application. iMedScan has a contract with various equipment leasing companies for the lease of the ATM machines at the healthcare facilities. The lease application, approval and funding can be facilitated in the blockchain digitized and confidential environment for the safety of the customer privacy and pertinent financial and credit information. iMedScan has contracts for insurance to insure the leased equipment.  The blockchain application will provide direct insurance underwriting securely with the insurance carrier to bind the insurance through a digitized and automated process upon approval of the lease.


Technology has been falling behind on secure, immutable technologies to keep safe the most important information of all: identity. The healthcare industry has been suffering the most from this, receiving threats from hackers to destroy or alter digital identities. iMedScan will build its patient database using an immutable distributed ledger to keep digital identities out of the hands of anybody but the healthcare facility itself. iMedScan will be one of the few healthcare technology companies launching a secure and digitized application for the storage and distribution of healthcare related patient records and financial information.


iMedScan recognizes the necessity at this early stage of its release of its application of having a solid financial and legal infrastructure to facilitate a high level of growth. Mr. Ortiz Morentin stated the company feels blockchain technology is certainly the future of business in today's technology age and we are proud to facilitate this transition.

Lastly, iMedScan is in discussion of utilizing an ICO or potentially a Token Launch to raise additional funds for the company in order to adequately launch a marketing platform for its iMedScan application. The Company is revamping its website,, to reflect the blockchain technology and expects it will be released live in the first quarter of 2018.


On October 27, 2017, the Company provided InMed Group with the required deposit to secure the Letter of Intent.

The Company has not engaged any Investor Relations group nor is the Company aware of any form of market awareness program to date. The Company monitors public bulleting boards to ensure, to the best of its ability, that there is no erroneous information disseminated.

Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Toron, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Toron, Inc. is unable to give any assurance that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include the company's ability to meet the conditions necessary to, among other matters, obtain a public listing on a major national exchange.

Editor's Details

Mike Wood

Last updated on: 17/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.